Elliot Stieglitz

University of California, San Francisco — United States

Medicine · Health Sciences

23h-index2.2kcitations211works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(84), Chronic Lymphocytic Leukemia Research(59), CAR-T cell therapy research(45), Chronic Myeloid Leukemia Treatments(42), Acute Lymphoblastic Leukemia research(31)

Publications211 total

Concurrent Juvenile Myelomonocytic Leukemia and Gliomas in Patients With Neurofibromatosis Type 1
Pediatric Blood & Cancer·2025Open Access
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
Blood Cancer Discovery·2025
COAGULATIVE ABNORMALITIES IN PATIENTS WITH CBL SYNDROME
EJC Paediatric Oncology·2025Open Access
CELLULAR IMMUNOTHERAPY TARGETING CLL-1 FOR JUVENILE MYELOMONOCYTIC LEUKEMIA
EJC Paediatric Oncology·2025Open Access
A phase I study of venetoclax in combination with multiagent cytotoxic chemotherapy for children and adolescents with relapsed or refractory acute lymphoblastic leukemia or mixed phenotype acute leukemia: Results of the dose determination cohort
Blood·2025Open Access
A human IL-6–Expressing PDX model of multiple myeloma recapitulates clinical features and supports patient-derived tumor engraftment
Blood·2025Open Access
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML
Blood·2025· 3 citedOpen Access
Daple-FLT3 (CCDC88C-FLT3) gene fusion requires the coiled-coil domain for maximal activation and pericentrosomal localization
2025Open Access
Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia
British Journal of Haematology·2025
Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML
Cell Reports·2025· 1 citedOpen Access
Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell–mediated lysis and express targetable antigens
Blood Neoplasia·2025Open Access
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia
2025Open Access
Biallelic SH2B3 germline variants are associated with a neonatal myeloproliferative disease and multisystemic involvement
European Journal of Human Genetics·2025· 6 citedOpen Access
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells
Blood·2025· 8 citedOpen Access
Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia
Nature Communications·2025· 1 citedOpen Access
<i>In vivo</i> validation of the palmitoylation cycle as a therapeutic target in <i>NRAS</i> -mutant cancer
2025Open Access
Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions
Blood Neoplasia·2025· 1 citedOpen Access
Azacytidine Monotherapy in an Infant With Mosaic <i>NRAS</i> ‐Driven Juvenile Myelomonocytic Leukemia
Pediatric Blood & Cancer·2025Open Access
Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies
Pediatric Blood & Cancer·2025· 1 citedOpen Access
<i>In Vivo</i> and <i>In Vitro</i> Chemical Synthetic Lethality of ABHD17 and MEK Inhibition in <i>NRAS</i>-Mutant Acute Myeloid Leukemia
Blood·2024· 2 cited
page 1 of 11Next →

Frequent Co-authors

Mignon L. Loh(26), Adam B. Olshen(7), Todd M. Cooper(6), Veronica Steri(6), Julia Meyer(5), Arun P. Wiita(5), Sarah K. Tasian(5), Christopher C. Dvorak(5), Juan A. Cámara(5), Paul Phojanakong(5), Peter D. Emanuel(4), Y. Lucy Liu(4), Huimin Geng(4), Martin Zenker(4), Gianina Wicaksono(4), Adila Izgutdina(4), Emilio Ramos(4), Fernando Salangsang(4), Laura C Gelston(3), Tali Mazor(3)